Close

June 1, 2016

Smoky Mountain Vapes, Inc. | FDA Snubs Senate Inquiry as Expected, Committee Will Pursue

I asked him what the next steps are for the Committee. He reports there are several steps to take with clear historic examples of how to proceed. The initial steps are simply “louder” requests, but should those requests remained unfulfilled, the eventual endpoint is a subpoena creating the opportunity for FDA management to be formally charged with contempt of Congress. I asked him what the Committee’s specific powers were to enforce changes on the FDA’s ruling. A direct answer to this question is too complicated for a simple phone call, most likely over-complicated because of the two centuries of precedence fueled by political maneuvering. But the general summary I can give from our conversation is direct action by the Committee will likely not be necessary. The Committee seeks first to expose information for the public. This information then becomes available to private interests who can and are filing lawsuits to stop the FDA. The Committee’s expectation is these lawsuits will be successful and they see their role as helping to bring relevant information to light to make these lawsuits easier to pursue.

Source: Smoky Mountain Vapes, Inc. | FDA Snubs Senate Inquiry as Expected, Committee Will Pursue

Leave a Reply

Your email address will not be published. Required fields are marked *